Patents by Inventor Alison Gardner

Alison Gardner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220238181
    Abstract: A system for selecting CRISPR guides for knocking out one or more target genes in a target cell from a multiplicity of candidate guides comprises a memory and a processor. The processor determines whether the candidate guide meets a plurality of thresholds. The thresholds are associated with: a transcript support level; targeting a consensus sequence of a target gene; which exon of the target gene is targeted; targeting of a primary transcript, targeting of a common isoform; a precomputed prediction of editing outcomes; mapping to an expressed sequence; fraction of gene expression attributable to targeted transcripts; a common SNP overlap threshold; which exon of the target gene is targeted; overlap of a selected guide; predicted frameshift percentage; maximum and minimum GC content; off target score; where a coding sequence is targeted. In response to meeting the thresholds, the processor selects the candidate guide as a selected CRISPR guide.
    Type: Application
    Filed: January 27, 2022
    Publication date: July 28, 2022
    Applicant: Recursion Pharmaceuticals, Inc.
    Inventors: James JENSEN, Timothy DAHLEM, Sarah HUGO, Jacob COOPER, Spencer SCHREIER, Ian QUIGLEY, Imran HAQUE, Nathan LAZAR, Alison GARDNER, Ben BANOWSKY, August ALLEN
  • Patent number: 7556920
    Abstract: An isolated nucleic acid molecule mapping to chromosome 16q24.3 and comprising the nucleotide sequence set forth in SEQ ID Numbers: 1 or 3.
    Type: Grant
    Filed: May 15, 2006
    Date of Patent: July 7, 2009
    Assignee: Bionomics Limited
    Inventors: David Frederick Callen, Jason Powell, Gabriel Kremmidiotis, Alison Gardner, Joanna Crawford, Anthony Bais, Marina Kochetkova
  • Publication number: 20070063675
    Abstract: Systems and methods are disclosed for providing battery health information to users of portable information handling systems. Battery health information is displayed to a user along with information concerning the limited life of a rechargeable battery. The battery health information may include, for example, a good condition indicator, a critical condition indicator and one or more intermediate condition levels. In addition, battery health information, customer battery usage information and other battery health related data can also be logged for later use in troubleshooting by users or remote technicians or for other desired purposes.
    Type: Application
    Filed: September 19, 2005
    Publication date: March 22, 2007
    Inventors: Erin Walline, Alan Becklein, Alison Gardner, Lakshmipriya Kothandaraman, Bruce Miller, Carrie Quintanilla
  • Publication number: 20060211033
    Abstract: An isolated nucleic acid molecule mapping to chromosome 16q24.3 and comprising the nucleotide sequence set forth in SEQ ID Numbers: 1 or 3.
    Type: Application
    Filed: May 15, 2006
    Publication date: September 21, 2006
    Inventors: David Callen, Jason Powell, Gabriel Kremmidiotis, Alison Gardner, Joanna Crawford, Anthony Bais, Marina Kochetkova
  • Patent number: 7083927
    Abstract: An isolated nucleic acid molecule mapping to chromosome 16q24.3 and comprising the nucleotide sequence set forth in SEQ ID Numbers: 1 or 3.
    Type: Grant
    Filed: January 31, 2002
    Date of Patent: August 1, 2006
    Assignee: Bionomics Limited
    Inventors: David Frederick Callen, Jason Powell, Gabriel Kremmidiotis, Alison Gardner, Joanna Crawford, Anthony Bais, Marina Kochetkova
  • Publication number: 20040170994
    Abstract: A method for the diagnosis of a predisposition thereto, in a patient, comprising the steps of: (1) establishing the level of expression of a gene selected from the group consisting of PR domain containing 7 protein (PRDM7), CDT1 DNA replication factor (CDT1), charged multivesicular body protein 1/chromoatin modifying protein 1 (CHMP1), BTG3 associated nucleoprotein (BANP), BNO224, BNO36, BNO34, BNO208, BNO230 and BNO44; and (2) comparing expression of the gene to a baseline established from expression in normal tissue controls; wherein substantial variance from the baseline indicates that the patient is susceptible to cancer.
    Type: Application
    Filed: August 7, 2003
    Publication date: September 2, 2004
    Inventors: David Frederick Callen, Gabriel Kremmidiotis, Scott Whitmore, Alison Gardner, Jason Powell
  • Publication number: 20040152873
    Abstract: An isolated nucleic acid molecule mapping to chromosome 16q24.3 and comprising the nucleotide sequence set forth in SEQ ID Numbers: 1 or 3.
    Type: Application
    Filed: July 29, 2003
    Publication date: August 5, 2004
    Inventors: Gabriel Frederick Callen, Jason Powell, Gabriel Kremmidiotis, Alison Gardner, Joanna Crawford, Anthony Bais, Marina Kochetkova